Prexxartan Solution
Product Images NDC 76281-155

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prexxartan (NDC 76281-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aptapharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Udc (76281 155 56 Udc Label)

Two circular labels for PREXXARTAN (valsartan) Oral Solution, 80 mg in 20 mL. Each label includes the NDC 76281-0155-56, barcode, Rx Only designation, and manufacturer information for AptaPharma Inc. for Carmel Biosciences, Inc., Atlanta, GA. One label has a blue outline with lot and expiration date, the other a purple outline.*

FDA Label Image

120 (76281 155 64 120ml)

Label for PREXXARTAN (valsartan) Oral Solution 20 mg/5 mL (4 mg/mL) in a 120 mL bottle. Manufactured by AptaPharma Inc. for Carmel Biosciences, Inc. The label includes storage instructions, inactive ingredients, dosage information, and a barcode. It is labeled Rx Only.*

FDA Label Image

473 (76281 155 82 473ml)

Label for Prexxartan Oral Solution, containing valsartan at a concentration of 4 mg/mL (20 mg/5 mL), in a 473 mL bottle. The label includes storage instructions (20°C to 25°C), inactive ingredients, and pharmacist dispensing directions. Manufactured by AptaPharma, Inc. for Carmel Biosciences, Inc.*

FDA Label Image

Trays (76281 155 99 Tray Label)

Label for PREXXARTAN (valsartan) oral solution, 80 mg/20 mL (4 mg/mL) in 20 mL unit dose cups. The label includes storage instructions, inactive ingredients, and manufacturer information: AptaPharma, Inc. for Carmel Biosciences, Inc., Atlanta, GA. It also features the product's NDC (76281-0155-99) and a barcode.*

FDA Label Image

Struct (Structure)

Chemical structure diagram of the active ingredient in PREXXARTAN 4 mg/mL oral solution by AptaPharma Inc. The diagram shows molecular bonds and groups typical for this compound.*

FDA Label Image

Study (Valiant Study)

A forest plot comparing the effects of Valsartan versus Captopril across various patient subgroups. The horizontal axis ranges from 0.5 to 1.5, with a reference line at 1.0, indicating the point of no difference. Data points with confidence intervals are plotted for subgroups including age, sex, race, region, and beta-blocker use, showing relative favorability toward Valsartan or Captopril.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.